Literature DB >> 33222811

Delivering Coordinated Cardio-Obstetric Care from Preconception through Postpartum.

Anna C O'Kelly1, Nandita Scott2, Doreen DeFaria Yeh3.   

Abstract

Coordinated preconception through postpartum cardio-obstetrics care is necessary to optimize both maternal and fetal health. Maternal mortality in the United States is increasing, largely driven by increasing cardiovascular (CV) disease burden during pregnancy and needs to be addressed emergently. Both for women with congenital and acquired heart disease, CV complications during pregnancy are associated with increased future risk of CV disease. Comprehensive cardio-obstetrics care is a powerful way of ensuring that women's CV risks before and during pregnancy are appropriately identified and treated and that they remain engaged in CV care long term to prevent future CV complications.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardio-obstetrics; Cardiovascular disease; Congenital heart disease; Coordinated care; Maternal mortality

Mesh:

Year:  2021        PMID: 33222811     DOI: 10.1016/j.ccl.2020.09.012

Source DB:  PubMed          Journal:  Cardiol Clin        ISSN: 0733-8651            Impact factor:   2.213


  3 in total

Review 1.  Pregnancy and Reproductive Risk Factors for Cardiovascular Disease in Women.

Authors:  Anna C O'Kelly; Erin D Michos; Chrisandra L Shufelt; Jane V Vermunt; Margo B Minissian; Odayme Quesada; Graeme N Smith; Janet W Rich-Edwards; Vesna D Garovic; Samar R El Khoudary; Michael C Honigberg
Journal:  Circ Res       Date:  2022-02-17       Impact factor: 17.367

2.  Diagnostic Value of Abdominal B-Ultrasound for Congenital Heart Disease Complicated with Extracardiac Malformation in the Second Trimester of Pregnancy.

Authors:  Yanming Deng; Lili Zhan; Zhouli Yu; Jianfang Wan
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-07       Impact factor: 2.650

3.  Risk Prediction Method of Obstetric Nursing Based on Data Mining.

Authors:  Deyan Jin
Journal:  Contrast Media Mol Imaging       Date:  2022-08-24       Impact factor: 3.009

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.